Solasia Pharma K.K.
Status: Publicly traded
Direct answer
Solasia Pharma K.K. is publicly traded on JPX under the ticker 4597.T.
Established in 2006 and headquartered in Tokyo, Japan, Solasia Pharma K.K. is dedicated to the development and commercialization of oncology treatments throughout Japan and other parts of Asia. The company's marketed products include SP-03 (episil oral liquid), designed for the protection and relief of oral pain and inflammation (mucositis/stomatitis) resulting from cancer chemotherapy and radiation. Additionally,...
Can you invest in Solasia Pharma K.K.?
Yes. Solasia Pharma K.K. trades publicly on JPX as 4597.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Solasia Pharma K.K.
Detailed equity research is provided by MarketSnap.